162 related articles for article (PubMed ID: 35791931)
1. [Ginsenoside Rg3 Regulates Cisplatin Resistance in Gastric Cancer by Wnt/β-catenin Signaling Pathway].
Meng ZQ; Zhang R; Wu XW; Jin TF; Zhang MH
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Jun; 44(3):366-376. PubMed ID: 35791931
[TBL] [Abstract][Full Text] [Related]
2. [miR-497 inhibits the growth and metastasis of SGC-7901 human gastric cancer anoikis resistant cells via blocking Wnt/β-catenin signaling pathway].
Yu L; Xu Y; Yang J; Gao L; Li H; Wang Z; Zhang Z; Ling Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Jul; 39(7):617-625. PubMed ID: 37403721
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of cytoplasmic GSK-3β increases cisplatin resistance through activation of Wnt/β-catenin signaling in A549/DDP cells.
Gao Y; Liu Z; Zhang X; He J; Pan Y; Hao F; Xie L; Li Q; Qiu X; Wang E
Cancer Lett; 2013 Aug; 336(1):231-9. PubMed ID: 23673211
[TBL] [Abstract][Full Text] [Related]
4. RKIP promotes cisplatin-induced gastric cancer cell death through NF-κB/Snail pathway.
Liu H; Li P; Li B; Sun P; Zhang J; Wang B; Jia B
Tumour Biol; 2015 Mar; 36(3):1445-53. PubMed ID: 25547433
[TBL] [Abstract][Full Text] [Related]
5. Gamma linolenic acid suppresses hypoxia-induced gastric cancer cell growth and epithelial-mesenchymal transition by inhibiting the Wnt/b-catenin signaling pathway.
Wang Y; Shi J; Gong L
Folia Histochem Cytobiol; 2020; 58(2):117-126. PubMed ID: 32608501
[TBL] [Abstract][Full Text] [Related]
6. BI2536, a potent and selective inhibitor of polo-like kinase 1, in combination with cisplatin exerts synergistic effects on gastric cancer cells.
Lian G; Li L; Shi Y; Jing C; Liu J; Guo X; Zhang Q; Dai T; Ye F; Wang Y; Chen M
Int J Oncol; 2018 Mar; 52(3):804-814. PubMed ID: 29393385
[TBL] [Abstract][Full Text] [Related]
7. TRAIL and Celastrol Combinational Treatment Suppresses Proliferation, Migration, and Invasion of Human Glioblastoma Cells via Targeting Wnt/β-catenin Signaling Pathway.
Qin JJ; Niu MD; Cha Z; Geng QH; Li YL; Ren CG; Molloy DP; Yu HR
Chin J Integr Med; 2024 Apr; 30(4):322-329. PubMed ID: 37861963
[TBL] [Abstract][Full Text] [Related]
8. BCL9 promotes epithelial mesenchymal transition and invasion in cisplatin resistant NSCLC cells via β-catenin pathway.
Zhang Y; Zhang Q; Chen H; Wang C
Life Sci; 2018 Sep; 208():284-294. PubMed ID: 30009824
[TBL] [Abstract][Full Text] [Related]
9. Ginsenoside Rg3 Inhibits the Growth of Osteosarcoma and Attenuates Metastasis through the Wnt/
Mao X; Jin Y; Feng T; Wang H; Liu D; Zhou Z; Yan Q; Yang H; Yang J; Yang J; Ye Y; Su Y; Zuo G
Evid Based Complement Alternat Med; 2020; 2020():6065124. PubMed ID: 32733585
[TBL] [Abstract][Full Text] [Related]
10. Toosendanin reduces cisplatin resistance in ovarian cancer through modulating the miR-195/ERK/β-catenin pathway.
Wang G; Li L; Li Y; Zhang LH
Phytomedicine; 2023 Jan; 109():154571. PubMed ID: 36610147
[TBL] [Abstract][Full Text] [Related]
11. Synergistic antitumor effect of ginsenoside Rg3 and cisplatin in cisplatin‑resistant bladder tumor cell line.
Lee YJ; Lee S; Ho JN; Byun SS; Hong SK; Lee SE; Lee E
Oncol Rep; 2014 Nov; 32(5):1803-8. PubMed ID: 25175462
[TBL] [Abstract][Full Text] [Related]
12. Ginsenoside Rb
Niu X; Shi Y; Li Q; Chen H; Fan X; Yu Y; Lv C; Lu J
Phytomedicine; 2023 Jul; 115():154776. PubMed ID: 37087793
[TBL] [Abstract][Full Text] [Related]
13. Baicalein enhanced cisplatin sensitivity of gastric cancer cells by inducing cell apoptosis and autophagy via Akt/mTOR and Nrf2/Keap 1 pathway.
Li P; Hu J; Shi B; Tie J
Biochem Biophys Res Commun; 2020 Oct; 531(3):320-327. PubMed ID: 32800561
[TBL] [Abstract][Full Text] [Related]
14. miR-34a regulates cisplatin-induce gastric cancer cell death by modulating PI3K/AKT/survivin pathway.
Cao W; Yang W; Fan R; Li H; Jiang J; Geng M; Jin Y; Wu Y
Tumour Biol; 2014 Feb; 35(2):1287-95. PubMed ID: 24068565
[TBL] [Abstract][Full Text] [Related]
15. Ginsenoside Rg3 inhibits the biological activity of SGC-7901.
Yang Q; Cai N; Che D; Chen X; Wang D
Food Sci Nutr; 2020 Aug; 8(8):4151-4158. PubMed ID: 32884696
[TBL] [Abstract][Full Text] [Related]
16. Stereospecific effects of ginsenoside 20-Rg3 inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses lung cancer migration, invasion and anoikis resistance.
Kim YJ; Choi WI; Jeon BN; Choi KC; Kim K; Kim TJ; Ham J; Jang HJ; Kang KS; Ko H
Toxicology; 2014 Aug; 322():23-33. PubMed ID: 24793912
[TBL] [Abstract][Full Text] [Related]
17. Ginsenoside Rg3 attenuates cisplatin resistance in lung cancer by downregulating PD-L1 and resuming immune.
Jiang Z; Yang Y; Yang Y; Zhang Y; Yue Z; Pan Z; Ren X
Biomed Pharmacother; 2017 Dec; 96():378-383. PubMed ID: 29031195
[TBL] [Abstract][Full Text] [Related]
18. Effects of ginsenoside compound K combined with cisplatin on the proliferation, apoptosis and epithelial mesenchymal transition in MCF-7 cells of human breast cancer.
Zhang K; Li Y
Pharm Biol; 2016; 54(4):561-8. PubMed ID: 26511312
[TBL] [Abstract][Full Text] [Related]
19. Ubiquitin-like modifier activating enzyme 2 promotes cell migration and invasion through Wnt/β-catenin signaling in gastric cancer.
Li J; Sun X; He P; Liu WQ; Zou YB; Wang Q; Meng XW
World J Gastroenterol; 2018 Nov; 24(42):4773-4786. PubMed ID: 30479464
[TBL] [Abstract][Full Text] [Related]
20. CUL4B promotes metastasis and proliferation in pancreatic cancer cells by inducing epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway.
He YM; Xiao YS; Wei L; Zhang JQ; Peng CH
J Cell Biochem; 2018 Jul; 119(7):5308-5323. PubMed ID: 29274277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
